With leading institutions such as the Canton of Vaud’s University Hospital (CHUV), University of Lausanne (UNIL) and the EPFL, the Lausanne-Montreux region stands out as an international centre of excellence in life sciences and healthcare.
The CHUV is behind major initiatives such as SwissNeuroTech, which is dedicated to the clinical evaluation of neurotechnologies, and the Lausanne Institutional Biobank (BIL), a key resource that plays an active role in advancing personalised medicine within Vaud’s academic and clinical ecosystem.
The region leads pioneering work in oncology, neurosciences, immunology, nutrition, and chronic diseases. It is also at the forefront of integrating artificial intelligence into bioinformatics, advanced medical imaging, and robotic surgery.
With more than 400 companies and laboratories active in life sciences and over 20,000 jobs, the canton of Vaud offers a thriving ecosystem where cutting-edge research meets industrial innovation, all in an exceptional living environment.
“The European Society of Gene and Cell Therapy was very happy to organise their annual congress in Lausanne. The city was chosen first for the strength of its local organising committee, which included renowned researchers in the field of gene and cell therapy. We were easily convinced that Lausanne would be the perfect city for us to organise this event mainly thanks to the state-of-the-art venue, which was without a doubt one of the best spaces we have ever had in many years of congress organising. Our delegates agreed, and scored the venue very highly in their event feedback. The size of the city and quality of the hotels, as well as the choice of excellent spaces for evening activities, were also important incentives in our choice. The congress went extremely well and definitely met ourselves’ and our delegates’ expectations.”
Gaëlle Jamar, Events Manager, ESCT – European Society of Gene and Cell Therapy